España
India
Italia
대한민ęµ
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민ęµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Stryker
SYK
NYSE
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Q4 2024 Earnings were released on Tue Jan 28th, after the market close
The most recent conference call was at 16:30 PM, 2 days ago
Click to view past webcast
Stryker (SYK) announced it will sell assets to Viscogliosi Brothers, LLC on Tuesday, January 28, 2025
Stryker (SYK) Forecast
News
Earnings
Stryker (SYK) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Stryker (NYSE:SYK) Stock
Stryker Stock (NYSE: SYK)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 30, 2025
Goldman Sachs Maintains Neutral on Stryker, R...
Benzinga Newsdesk
Truist Securities Maintains Hold on Stryker, ...
Benzinga Newsdesk
Wednesday, January 29, 2025
A Glimpse Into The Expert Outlook On Stryker Through 14 Analysts
Benzinga Insights
Stryker's Strategic Moves Impress Analysts, Spine Implant Sale and NARI Deal Set to Drive Future Growth
Anusuya Lahiri
RBC Capital Maintains Outperform on Stryker, ...
Benzinga Newsdesk
Wells Fargo Maintains Overweight on Stryker, ...
Benzinga Newsdesk
Starbucks To Rally Over 23%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
JP Morgan Maintains Overweight on Stryker, Ra...
Benzinga Newsdesk
Stifel Maintains Buy on Stryker, Raises Price...
Benzinga Newsdesk
Canaccord Genuity Maintains Buy on Stryker, R...
Benzinga Newsdesk
Needham Reiterates Buy on Stryker, Maintains ...
Benzinga Newsdesk
US Futures Point To Cautious Start As Investors Await Fed's Rate Decision: Tesla, Microsoft, Meta Among Stocks In Focus Ahead Of Earnings
Rishabh Mishra
Tesla, Starbucks And 3 Stocks To Watch Heading Into Wednesday
Avi Kapoor
Tuesday, January 28, 2025
Stryker Earnings Report: Q4 Overview
Benzinga Insights
Stryker Earnings Review: Q4 Summary
Benzinga Insights
Stryker Earnings Analysis: Q4 Recap
Benzinga Insights
Stryker shares are trading lower following Q4...
Benzinga Newsdesk
Stryker Q4 Earnings Assessment
Benzinga Insights
Insights into Stryker Q4 Earnings
Benzinga Insights
Earnings Summary: Stryker Q4
Benzinga Insights
Stryker Expects FY25 Organic Net Sales Growth...
Benzinga Newsdesk
Stryker CFO Glenn Boehnlein To Retire; Presto...
Benzinga Newsdesk
Stryker Q4 2024 Adj EPS $4.01 Beats $3.87 Est...
Benzinga Newsdesk
Earnings Scheduled For January 28, 2025
Benzinga Insights
Tuesday, January 21, 2025
Stryker shares are trading higher after the c...
Benzinga Newsdesk
Friday, January 17, 2025
Stryker Commences Tender Offer For All Outsta...
Benzinga Newsdesk
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Benzinga Insights
How Is The Market Feeling About Stryker?
Benzinga Insights
Sunday, January 12, 2025
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
Lekha Gupta
Tuesday, January 07, 2025
JMP Securities Reiterates Market Perform on S...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on Stryker,...
Benzinga Newsdesk
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
Vandana Singh
Needham Reiterates Buy on Stryker, Maintains ...
Benzinga Newsdesk
Why Inari Medical Shares Are Trading Higher By 21%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Monday, January 06, 2025
Stryker To Acquire Inari Medical For $80/Shar...
Benzinga Newsdesk
Stryker Corp Is Nearing A Deal To Acquire In...
Benzinga Newsdesk
Friday, January 03, 2025
Here's How Much You Would Have Made Owning Stryker Stock In The Last 20 Years
Benzinga Insights
Insider Activity Update: Glenn S Boehnlein Executes Options Exercise, Resulting In $71K At Stryker
Benzinga Insights
Tuesday, December 31, 2024
Glenn S Boehnlein At Stryker Executes Options Exercise, Realizing $479K
Benzinga Insights
Wednesday, December 18, 2024
Truist Securities Maintains Hold on Stryker, ...
Benzinga Newsdesk
Monday, December 16, 2024
How Is The Market Feeling About Stryker?
Benzinga Insights
Here's How Much You Would Have Made Owning Stryker Stock In The Last 10 Years
Benzinga Insights
Thursday, December 12, 2024
PepsiCo To Rally Over 17%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
Needham Maintains Buy on Stryker, Raises Pric...
Benzinga Newsdesk
Wednesday, December 11, 2024
Citigroup Maintains Buy on Stryker, Raises Pr...
Benzinga Newsdesk
RBC Capital Reiterates Outperform on Stryker,...
Benzinga Newsdesk
Wells Fargo Maintains Overweight on Stryker, ...
Benzinga Newsdesk
Monday, December 02, 2024
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Vandana Singh
Cracking The Code: Understanding Analyst Reviews For Stryker
Benzinga Insights
This Gap Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Avi Kapoor
Show More